TABLE 2

Clinical characteristics of the subjects

EU groupHY group
n66
Age (years)32 ± 431 ± 3
BMI (kg/m2)23 ± 0.323 ± 0.8
HbA1c (%)*7.7 ± 0.47.5 ± 0.4
Diabetes duration (years)13 ± 210 ± 3
Body surface area (m2)1.9 ± 0.012.0 ± 0.05
Body weight (kg)75 ± 278 ± 3
Total cholesterol (mmol)4.4 ± 0.44.2 ± 0.3
LDL cholesterol (mmol)2.7 ± 0.32.6 ± 0.3
HDL cholesterol (mmol)1.4 ± 0.21.3 ± 0.1
Triglyceride (mmol)0.9 ± 0.20.7 ± 0.1
Actrapid dose (IU/day)32 ± 1.530 ± 1.2
Insulatard dose (IU/day)22 ± 323 ± 4
  • Data are mean ± SE.

  • *

    * Reference interval for HbA1c is 4.7–7.0%. EU, euglycemic; HY, hyperglycemic.